Business Context and Reporting Period
Lifemd, Inc. (LFMD) filed a Form 8-K on November 5, 2025, to disclose a rescheduling of its third-quarter 2025 earnings release and conference call. The new date is set for Monday, November 17, 2025. This filing also anticipates a late filing of the Form 10-Q for the period ended September 30, 2025, via a Form 12b-25.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures for the current period. However, it quantifies the impact of identified accounting corrections:
- Cumulative Adjustment: Approximately $4.6 million.
- Impact on Revenue: Approximately 1.4% of cumulative revenue reported for the twelve months ended December 31, 2024, and the six months ended June 30, 2025.
- Cash Flow Impact: The adjustments will not impact the Company's cash flow or cash position.
Material Changes and Accounting Corrections
The delay in reporting is due to corrections identified following data system migrations. These corrections relate to the recognition of revenue and offsetting related balance sheet accounts for the periods ending December 31, 2024, and June 30, 2025. Management assesses that these adjustments will not materially impact how reported revenue results compare to guidance for the affected reporting periods.
Outlook, Risks, and Management Commentary
Management expects to issue the Q3 2025 earnings press release on or around 4:05 p.m. Eastern time on November 17, 2025, followed by a conference call at 4:30 p.m. Eastern time. The filing includes significant forward-looking statements regarding the evaluation of these errors and their potential impact on internal controls over financial reporting. The Company notes that preliminary determinations are subject to adjustment and have not been audited or reviewed by external auditors.
Investor Verification Checklist
- Verify the final Form 10-Q for the period ended September 30, 2025, once filed, to confirm the exact nature of the revenue recognition adjustments.
- Monitor the upcoming Form 12b-25 filing to confirm the official late filing status of the Q3 2025 report.
- Review the November 17, 2025, earnings call for details on the impact of these corrections on internal control over financial reporting.
- Confirm whether the $4.6 million adjustment affects any prior period guidance or analyst expectations beyond the stated 1.4% revenue impact.